Evidence map›Paper›PMID 40677405›Full record

ArticleMaterials today. Bio2025

BMSCs-targeting piezoelectric stimulation and immunomodulatory dual-functional hydrogel for promoting diabetic bone regeneration.

Jintao Dong, Wengang Dong, Huijie Ran, Dongxu Wu, Xinli Wang, Hongli Chen, Jiahao Cao, Xu Wang, Xinsen Lin, Wei Lei and 2 more

Erratum issuedAbstract read
In one paragraph

Article in Materials today. Bio, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. (Ba,Ca)(Ti,Sn)OFrontiers in cellular neuroscience · 2026
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Jintao DongDepartment of Orthopedics, Xijing Hospital, The Fourth Military Medical University, Xi'an, 710032, China.
Wengang DongDepartment of Orthopedics, Xijing Hospital, The Fourth Military Medical University, Xi'an, 710032, China.
Huijie RanNorthwestern Polytechnical University, 127 Youyi West Road, Beilin District, Xi 'an City, Shaanxi Province, 710072, China.
Dongxu WuSchool of Basic Medical Sciences, The Fourth Military Medical University, Xi'an, 710032, China.
Xinli WangDepartment of Orthopedics, Xijing Hospital, The Fourth Military Medical University, Xi'an, 710032, China.
Hongli ChenDepartment of Orthopedics, Xijing Hospital, The Fourth Military Medical University, Xi'an, 710032, China.
Jiahao CaoDepartment of Orthopedics, Xijing Hospital, The Fourth Military Medical University, Xi'an, 710032, China.
Xu WangDepartment of Orthopedics, Xijing Hospital, The Fourth Military Medical University, Xi'an, 710032, China.
Xinsen LinDepartment of Orthopedics, Xijing Hospital, The Fourth Military Medical University, Xi'an, 710032, China.
Wei LeiDepartment of Orthopedics, Xijing Hospital, The Fourth Military Medical University, Xi'an, 710032, China.
Tianji WangDepartment of Interventional Surgery Center, Xijing Hospital, The Fourth Military Medical University, Xi'an, 710032, China.
Yafei FengDepartment of Orthopedics, Xijing Hospital, The Fourth Military Medical University, Xi'an, 710032, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bone regeneration in diabetic patients poses a significant clinical challenge due to persistent hyperglycemia and chronic inflammation, which disrupt the crucial interaction between the immune microenvironment and bone marrow-derived mesenchymal stem cells (BMSCs), thereby impairing osteogenesis. To address this limitation, ultrasonic-responsive barium titanate (BTO) nanoparticles were coated with BMSC membranes (B-TNs) and subsequently integrated into a carboxylated modified silk fibroin (CMS) hydrogel. This resulted in a dual-functional B-TNs@CMS composite hydrogel designed to combine targeted BMSC stimulation with immunomodulatory properties. Under diabetic conditions, the composite hydrogel facilitated macrophage polarization from the pro-inflammatory M1 phenotype to the anti-inflammatory M2 phenotype. Proteomic analysis and validation assays demonstrated that CMS reprograms macrophages through the PI3K-Akt-mTORC1 signaling axis, thereby restoring an osteogenesis-supportive immune microenvironment conducive to osteogenesis. Simultaneously, the degradation of CMS released B-TNs, which produced a moderate level of reactive oxygen species (ROS) under optimized extracorporeal ultrasound (US) stimulation. This process activated Wnt/β-catenin signaling, enhancing BMSC proliferation and osteogenic differentiation. This study highlights the significant potential of a dual-modular strategy integrating immune modulation with spatially targeted osteogenic stimulation, offering a promising therapeutic approach for diabetic bone regeneration.

Indexed as

Bone healingCarboxylated modified silk fibroinDiabetes mellitusImmune-osteogenic homeostasisTargeted BMSC stimulation

Identifiers

PMID40677405
PMCPMC12269990

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.